177 related articles for article (PubMed ID: 31796842)
1. Participation of 5-lipoxygenase and LTB4 in liver regeneration after partial hepatectomy.
Lorenzetti F; Vera MC; Ceballos MP; Ronco MT; Pisani GB; Monti JA; Lucci A; Comanzo CG; Tordjmann T; Carrillo MC; Quiroga AD; Alvarez ML
Sci Rep; 2019 Dec; 9(1):18176. PubMed ID: 31796842
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of 5-lipoxygenase promotes the regeneration of the liver after partial hepatectomy in normal and icteric rats.
Urade M; Izumi R; Kitagawa H
Hepatology; 1996 Mar; 23(3):544-8. PubMed ID: 8617435
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Leukotriene B4 Action Mitigates Intracerebral Hemorrhage-Associated Pathological Events in Mice.
Hijioka M; Anan J; Ishibashi H; Kurauchi Y; Hisatsune A; Seki T; Koga T; Yokomizo T; Shimizu T; Katsuki H
J Pharmacol Exp Ther; 2017 Mar; 360(3):399-408. PubMed ID: 28035009
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of 5-lipoxygenase represses neutrophils activation and activates apoptosis in pancreatic tissues during acute necrotizing pancreatitis.
Liao D; Qian B; Zhang Y; Wu K; Xu M
Biochem Biophys Res Commun; 2018 Mar; 498(1):79-85. PubMed ID: 29421656
[TBL] [Abstract][Full Text] [Related]
5. Hypercholesterolemia increases the production of leukotriene B4 in neutrophils by enhancing the nuclear localization of 5-lipoxygenase.
Lai XF; Qin HD; Guo LL; Luo ZG; Chang J; Qin CC
Cell Physiol Biochem; 2014; 34(5):1723-32. PubMed ID: 25428728
[TBL] [Abstract][Full Text] [Related]
6. Naja sputatrix Venom Preconditioning Attenuates Neuroinflammation in a Rat Model of Surgical Brain Injury via PLA2/5-LOX/LTB4 Cascade Activation.
Wang Y; Sherchan P; Huang L; Akyol O; McBride DW; Zhang JH
Sci Rep; 2017 Jul; 7(1):5466. PubMed ID: 28710425
[TBL] [Abstract][Full Text] [Related]
7. Pre-clinical pharmacology of ICI D2138, a potent orally-active non-redox inhibitor of 5-lipoxygenase.
McMillan RM; Spruce KE; Crawley GC; Walker ER; Foster SJ
Br J Pharmacol; 1992 Dec; 107(4):1042-7. PubMed ID: 1334748
[TBL] [Abstract][Full Text] [Related]
8. Autocrine enhancement of leukotriene synthesis by endogenous leukotriene B4 and platelet-activating factor in human neutrophils.
McDonald PP; McColl SR; Braquet P; Borgeat P
Br J Pharmacol; 1994 Mar; 111(3):852-60. PubMed ID: 8019762
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of 5-lipoxygenase alleviates graft-versus-host disease.
Rezende BM; Athayde RM; Gonçalves WA; Resende CB; Teles de Tolêdo Bernardes P; Perez DA; Esper L; Reis AC; Rachid MA; Castor MGME; Cunha TM; Machado FS; Teixeira MM; Pinho V
J Exp Med; 2017 Nov; 214(11):3399-3415. PubMed ID: 28947611
[TBL] [Abstract][Full Text] [Related]
10. A rat air pouch model for evaluating the efficacy and selectivity of 5-lipoxygenase inhibitors.
Zweifel BS; Hardy MM; Anderson GD; Dufield DR; Pufahl RA; Masferrer JL
Eur J Pharmacol; 2008 Apr; 584(1):166-74. PubMed ID: 18295198
[TBL] [Abstract][Full Text] [Related]
11. Role of eicosanoids in liver repair, regeneration and cancer.
Alvarez ML; Lorenzetti F
Biochem Pharmacol; 2021 Oct; 192():114732. PubMed ID: 34411565
[TBL] [Abstract][Full Text] [Related]
12. Possible involvement of the lipoxygenase and leukotriene signaling pathways in cisplatin-mediated renal toxicity.
Alkhamees OA; Alroujayee AS; Abuohashish HM; Alrojayee FS; Ahmed MM
Cancer Chemother Pharmacol; 2017 Jul; 80(1):55-64. PubMed ID: 28502039
[TBL] [Abstract][Full Text] [Related]
13. Calcium-dependent eicosanoid metabolism by concanavalin A-stimulated human monocytes in vitro. Synergism with phorbol ester indicates separate regulation of leukotriene B4 synthesis and release.
Hoffman T; Brando C; Lizzio EF; Lee YL; Hansen M; Tripathi AK; Taplits M; Puri J; Bonvini E; Abrahamsen TG
J Immunol; 1991 Jan; 146(2):692-700. PubMed ID: 1846160
[TBL] [Abstract][Full Text] [Related]
14. Blocking macrophage leukotriene b4 prevents endothelial injury and reverses pulmonary hypertension.
Tian W; Jiang X; Tamosiuniene R; Sung YK; Qian J; Dhillon G; Gera L; Farkas L; Rabinovitch M; Zamanian RT; Inayathullah M; Fridlib M; Rajadas J; Peters-Golden M; Voelkel NF; Nicolls MR
Sci Transl Med; 2013 Aug; 5(200):200ra117. PubMed ID: 23986401
[TBL] [Abstract][Full Text] [Related]
15. Eicosanoid pathway on host resistance and inflammation during Mycobacterium tuberculosis infection is comprised by LTB
Sorgi CA; Soares EM; Rosada RS; Bitencourt CS; Zoccal KF; Pereira PAT; Fontanari C; Brandão I; Masson AP; Ramos SG; Silva CL; Frantz FG; Faccioli LH
Biochim Biophys Acta Mol Basis Dis; 2020 Mar; 1866(3):165574. PubMed ID: 31666208
[TBL] [Abstract][Full Text] [Related]
16. Role of 5-lipoxygenase pathway in the regulation of RAW 264.7 macrophage proliferation.
Nieves D; Moreno JJ
Biochem Pharmacol; 2006 Oct; 72(8):1022-30. PubMed ID: 16934759
[TBL] [Abstract][Full Text] [Related]
17. Disrupted NF- kappa B activation after partial hepatectomy does not impair hepatocyte proliferation in rats.
Laurent S; Horsmans Y; Stärkel P; Leclercq I; Sempoux C; Lambotte L
World J Gastroenterol; 2005 Dec; 11(46):7345-50. PubMed ID: 16437640
[TBL] [Abstract][Full Text] [Related]
18. Pharmacodynamic and pharmacokinetic characterisation of RBx 7796: a novel 5-lipoxygenase inhibitor.
Shirumalla RK; Sharma P; Dastidar SG; Paliwal JK; Kakar S; Varshney B; Singh Saini G; Sattigeri V; Salman M; Ray A
Inflamm Res; 2008 Mar; 57(3):135-43. PubMed ID: 18369577
[TBL] [Abstract][Full Text] [Related]
19. Hepatocellular carcinoma progression promoted by 5-lipoxygenase activity in CD163(+) tumor-associated macrophages.
Nosaka T; Murata Y; Takahashi K; Naito T; Ofuji K; Matsuda H; Ohtani M; Hiramatsu K; Imamura Y; Goi T; Nakamoto Y
Biomed Pharmacother; 2023 Jun; 162():114592. PubMed ID: 36966664
[TBL] [Abstract][Full Text] [Related]
20. Lipid metabolism enzyme 5-LOX and its metabolite LTB4 are capable of activating transcription factor NF-κB in hepatoma cells.
Zhao Y; Wang W; Wang Q; Zhang X; Ye L
Biochem Biophys Res Commun; 2012 Feb; 418(4):647-51. PubMed ID: 22293202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
